Maxcyte, Inc.
A maker of electroporation instruments and technology that help scientists slip genetic material like mRNA and DNA into living cells — a key step in building cell and gene therapies and vaccines. Its Flow Electroporation platform is used by biopharma companies and researchers to engineer cells for treating disease. Founded in 1999 in Gaithersburg, Maryland, the company's name blends "maximum" and "cyte" (the Greek root for cell), reflecting its goal of getting the most out of every engineered cell.
Granted 300.0K
Granted 30.4K
Granted 30.4K
Granted 30.4K
Granted 187.5K
Granted 30.4K
Sold 10.1K
Granted 30.4K
Granted 30.4K
Granted 30.4K
Granted 30.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Masoud MaherPresident and CEO, Director · 1 transaction | +171.4% | 475.0K | 300.0K | — | — |
| Erck Stanley CDirector · 1 transaction | +7.6% | 428.7K | 30.4K | — | — |
| Douglas RichardDirector · 1 transaction | +13.2% | 261.0K | 30.4K | — | — |
| Johnston John JosephDirector · 1 transaction | +17.8% | 201.6K | 30.4K | — | — |
| Ahuja ParmeetChief Financial Officer · 1 transaction | — | 187.5K | 187.5K | — | — |
| Brooke William WDirector · 1 transaction | +20.2% | 181.3K | 30.4K | — | — |
| Swirsky Douglas JCHIEF FINANCIAL OFFICER · 1 transaction | -6.3% | 151.7K | — | — | 10.1K |
| Collins CynthiaDirector · 1 transaction | +37.6% | 111.3K | 30.4K | — | — |
| Al-Wakeel Yasir B.Director · 1 transaction | +60.1% | 81.0K | 30.4K | — | — |
| Balthrop Patrick JDirector · 1 transaction | +60.1% | 81.0K | 30.4K | — | — |
| Hemrajani RekhaDirector · 1 transaction | +76.3% | 70.3K | 30.4K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last 6 months: -10.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.